Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy


AYDINER A. , Sari M.

JOURNAL OF CLINICAL ONCOLOGY, cilt.36, 2018 (SCI İndekslerine Giren Dergi) identifier